IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms

por Kuo, Be-Sheng, Li, Chao-Hung, Chen, Jiun-Bo, Shiung, Yu-Yu, Chu, Chia-Yu, Lee, Chih-Hung, Liu, Yaw-Jen, Kuo, Je-Hung, Hsu, Cindy, Su, Hsiao-Wen, Li, Ywan-Feng, Lai, Annie, Ho, Yueh-Feng, Cheng, Yi-Ning, Huang, Hong-Xuan, Lung, Meng-Chung, Wu, Ming-Syue, Yang, Fu-Hung, Lin, Chen-Han, Tseng, William, Yang, Jasper, Lin, Chia-Yin, Tsai, Pei-Hua, Chang, Heng-Kwei, Wang, Yi-Jen, Chen, Techeng, Lynn, Shugene, Liao, Mei-June, Wang, Chang Yi
Publicado 2022